EUVIMEDEUVIMED entdecken
Crossref

Identification of novel signal of proton pump inhibitor-associated drug reaction with eosinophilia and systemic symptoms: a disproportionality analysis

Wanshu Li, Yanan Yu, Minghui Li, Qing Fang, Xin Jin, Hangjuan Lin, Jun Xu

International Journal of Clinical Pharmacy · 2024

DOI: 10.1007/s11096-024-01778-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Clinical Pharmacy, 2024. Verfasst von Wanshu Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Ningbo Municipal Hospital of Traditional Chinese Medicine (TCM), Affiliated Hospital of Zhejiang Chinese Medical University, …. Hauptthemen laut MEDLINE: Proton Pump Inhibitors, Adverse Drug Reaction Reporting Systems, Drug Hypersensitivity Syndrome. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: NINGBO Medical & Health Leading Academic Discipline Project, NINGBO Medical & Health Brand Discipline Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Proton pump inhibitors (PPIs) are commonly prescribed for treating upper gastrointestinal hemorrhage, eradicating Helicobacter pylori, and stress ulcer prophylaxis, among other digestive system diseases. Recent case reports provided limited evidence of a correlation between PPIs and drug reactions with eosinophilia and systemic symptoms (DRESS). However, there is currently no established association between PPIs and DRESS. AIM: This research aimed to identify the associations between PPIs and DRESS using the US Food and Drug Administration Adverse Events Reporting System (FAERS) database. METHOD: A retrospective investigation of DRESS associated with six PPIs used FAERS data from Q1 2004 to Q3 2023. Data mining algorithms were used to identify adverse events in the FAERS database that met the following criteria: (1) proportional reporting ratio (PRR) ≥ 2; (2) reporting odds ratio (ROR) > 1; (3) 95% confidence interval (CI) of ROR > 1; (4) Chi-square (χ2) ≥ 4 and case count ≥ 3. RESULTS: There were 495 reports of PPI-related DRESS, including pantoprazole (174, 35.2%), omeprazole (103, 20.8%), lansoprazole (103, 20.8%), esomeprazole (101, 20.4%), rabeprazole (8, 1.6%), and dexlansoprazole (6, 1.2%). The results indicated a significant association of three PPIs (pantoprazole, omeprazole, and lansoprazole) with DRESS. The sensitivity analysis demonstrated that only pantoprazole remained significantly associated with DRESS after 10 concomitant drugs had been removed (ROR: 3.00, PRR: 2.99, and information component [IC]: 1.57). CONCLUSION: This study identified the signals suggesting a potential association between DRESS and six PPIs. However, more investigation of epidemiological data is required to validate of these conclusions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proton Pump InhibitorsAdverse Drug Reaction Reporting SystemsDrug Hypersensitivity SyndromeHumansRetrospective StudiesFemaleMaleMiddle AgedAdultAgedUnited StatesDatabases, FactualUnited States Food and Drug AdministrationYoung AdultAdolescentData MiningAged, 80 and over

Stichwörter der Autor:innen

Disproportionality analysisDrug reaction with eosinophilia systemic symptoms (DRESS)FAERSProton pump inhibitors

Substanzen

Proton Pump Inhibitors

Autor:innen und Institutionen

  • Department of Pharmacy, Ningbo Municipal Hospital of Traditional Chinese Medicine (TCM), Affiliated Hospital of Zhejiang Chinese Medical University, Ningbo, 315010, Zhejiang, China.
  • Department of Nursing, Ningbo Municipal Hospital of Traditional Chinese Medicine (TCM), Affiliated Hospital of Zhejiang Chinese Medical University, Ningbo, 315010, Zhejiang, China. Xujun8000@163.com.

Förderung

  • NINGBO Medical & Health Leading Academic Discipline Project
  • NINGBO Medical & Health Brand Discipline Project

Zitieren

APA

Li, W., Yu, Y., Li, M., Fang, Q., Jin, X., Lin, H., & Xu, J. (2024). Identification of novel signal of proton pump inhibitor-associated drug reaction with eosinophilia and systemic symptoms: a disproportionality analysis. International Journal of Clinical Pharmacy. https://doi.org/10.1007/s11096-024-01778-y

Vancouver

Li W, Yu Y, Li M, Fang Q, Jin X, Lin H, et al. Identification of novel signal of proton pump inhibitor-associated drug reaction with eosinophilia and systemic symptoms: a disproportionality analysis. International Journal of Clinical Pharmacy. 2024. doi:10.1007/s11096-024-01778-y

BibTeX
@article{Li2024,
  author = {Li, Wanshu and Yu, Yanan and Li, Minghui and Fang, Qing and Jin, Xin and Lin, Hangjuan and Xu, Jun},
  title = {Identification of novel signal of proton pump inhibitor-associated drug reaction with eosinophilia and systemic symptoms: a disproportionality analysis},
  journal = {International Journal of Clinical Pharmacy},
  year = {2024},
  doi = {10.1007/s11096-024-01778-y}
}
Kostenlos starten →